Microenvironmental regulation of solid tumour resistance to CAR T cell therapy
{{output}}
Chimeric antigen receptor (CAR) T cell therapy holds significant promise for the treatment of cancer; however, its efficacy in solid tumours is substantially hindered by the immunosuppressive tumour microenvironment (TME). Solid tumours can resist immunotherap... ...
